CN101629162A - Cell sheet engineering and preparation method thereof - Google Patents
Cell sheet engineering and preparation method thereof Download PDFInfo
- Publication number
- CN101629162A CN101629162A CN200910042147A CN200910042147A CN101629162A CN 101629162 A CN101629162 A CN 101629162A CN 200910042147 A CN200910042147 A CN 200910042147A CN 200910042147 A CN200910042147 A CN 200910042147A CN 101629162 A CN101629162 A CN 101629162A
- Authority
- CN
- China
- Prior art keywords
- cell sheet
- hydrogel
- cell
- cells
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000012407 engineering method Methods 0.000 title 1
- 210000004027 cell Anatomy 0.000 claims abstract description 156
- 239000000017 hydrogel Substances 0.000 claims abstract description 87
- 238000000034 method Methods 0.000 claims abstract description 54
- 230000005855 radiation Effects 0.000 claims abstract description 41
- 238000004113 cell culture Methods 0.000 claims abstract description 27
- 239000000853 adhesive Substances 0.000 claims abstract description 17
- 230000001070 adhesive effect Effects 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 230000008859 change Effects 0.000 claims abstract description 7
- 238000001179 sorption measurement Methods 0.000 claims abstract description 6
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 5
- 229920005597 polymer membrane Polymers 0.000 claims abstract description 5
- 239000000178 monomer Substances 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims description 18
- 238000003786 synthesis reaction Methods 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- 239000003431 cross linking reagent Substances 0.000 claims description 12
- 239000012460 protein solution Substances 0.000 claims description 11
- 239000004793 Polystyrene Substances 0.000 claims description 10
- 229920002223 polystyrene Polymers 0.000 claims description 10
- -1 polytetrafluoroethylene Polymers 0.000 claims description 7
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 7
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 210000004748 cultured cell Anatomy 0.000 claims description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 5
- 108010049003 Fibrinogen Proteins 0.000 claims description 4
- 102000008946 Fibrinogen Human genes 0.000 claims description 4
- 108010067306 Fibronectins Proteins 0.000 claims description 4
- 102000016359 Fibronectins Human genes 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 229940012952 fibrinogen Drugs 0.000 claims description 4
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenylpropanol Natural products OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- 108010089975 arginyl-glycyl-aspartyl-serine Proteins 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 102000012422 Collagen Type I Human genes 0.000 claims description 2
- 108010022452 Collagen Type I Proteins 0.000 claims description 2
- 102000004266 Collagen Type IV Human genes 0.000 claims description 2
- 108010042086 Collagen Type IV Proteins 0.000 claims description 2
- 108090000190 Thrombin Proteins 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 229960004072 thrombin Drugs 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 38
- 108010052285 Membrane Proteins Proteins 0.000 abstract description 2
- 102000000591 Tight Junction Proteins Human genes 0.000 abstract description 2
- 108010002321 Tight Junction Proteins Proteins 0.000 abstract description 2
- 210000002469 basement membrane Anatomy 0.000 abstract description 2
- 210000001047 desmosome Anatomy 0.000 abstract description 2
- 102000006495 integrins Human genes 0.000 abstract description 2
- 108010044426 integrins Proteins 0.000 abstract description 2
- 210000004692 intercellular junction Anatomy 0.000 abstract description 2
- 210000001578 tight junction Anatomy 0.000 abstract description 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 description 48
- 210000002536 stromal cell Anatomy 0.000 description 46
- 238000002054 transplantation Methods 0.000 description 37
- 239000002131 composite material Substances 0.000 description 25
- 238000006116 polymerization reaction Methods 0.000 description 18
- 238000010276 construction Methods 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 13
- 210000000399 corneal endothelial cell Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 230000002207 retinal effect Effects 0.000 description 9
- 210000000844 retinal pigment epithelial cell Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 8
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 7
- 238000012136 culture method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 210000004413 cardiac myocyte Anatomy 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 3
- 208000031737 Tissue Adhesions Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 238000010382 chemical cross-linking Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000003511 endothelial effect Effects 0.000 description 3
- 230000006862 enzymatic digestion Effects 0.000 description 3
- 210000003560 epithelium corneal Anatomy 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- NNRFRJQMBSBXGO-CIUDSAMLSA-N (3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NNRFRJQMBSBXGO-CIUDSAMLSA-N 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 2
- 208000018380 Chemical injury Diseases 0.000 description 2
- 206010055665 Corneal neovascularisation Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 2
- 102000035092 Neutral proteases Human genes 0.000 description 2
- 108091005507 Neutral proteases Proteins 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000000159 corneal neovascularization Diseases 0.000 description 2
- 210000003683 corneal stroma Anatomy 0.000 description 2
- 239000011557 critical solution Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 210000005081 epithelial layer Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 206010023365 keratopathy Diseases 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 210000002379 periodontal ligament Anatomy 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- YICILWNDMQTUIY-UHFFFAOYSA-N 2-methylidenepentanamide Chemical compound CCCC(=C)C(N)=O YICILWNDMQTUIY-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- 206010011033 Corneal oedema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 101000829980 Homo sapiens Ral guanine nucleotide dissociation stimulator Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 206010072138 Limbal stem cell deficiency Diseases 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 206010067776 Ocular pemphigoid Diseases 0.000 description 1
- 208000023715 Ocular surface disease Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- ORFPWVRKFLOQHK-UHFFFAOYSA-N amicarbazone Chemical compound CC(C)C1=NN(C(=O)NC(C)(C)C)C(=O)N1N ORFPWVRKFLOQHK-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000010002 cicatricial pemphigoid Diseases 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 201000004778 corneal edema Diseases 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 230000004453 corneal transparency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000001153 interneuron Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 210000004261 periodontium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000010069 protein adhesion Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001164 retinal progenitor cell Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明属于组织工程领域,具体涉及一种组织工程细胞片及其制备方法。该细胞片通过以下方法制备:首先通过电子加速器辐射在细胞培养支持物表面合成聚N-异丙基丙烯酰胺水凝胶;然后控制温度使聚N-异丙基丙烯酰胺水凝胶为疏水相,在此相上培养细胞;改变温度,使水凝胶为亲水相,通过高分子膜吸附或夹具钳夹方法,分离出组织工程细胞片。得到的细胞片通过多层化培养或者通过蛋白黏附液黏附得到多层细胞片。本发明得到的细胞片可以保持细胞与细胞间的桥粒结构、ZO-1紧密连接结构和其它细胞间连接结构,可以保留基底膜蛋白及其与黏合有关的许多成分如整合素等,还具有一定的强度。
The invention belongs to the field of tissue engineering, and in particular relates to a tissue engineering cell sheet and a preparation method thereof. The cell sheet is prepared by the following method: first, polyN-isopropylacrylamide hydrogel is synthesized on the surface of the cell culture support by electron accelerator radiation; then the polyN-isopropylacrylamide hydrogel is a hydrophobic phase by controlling the temperature , culture cells on this phase; change the temperature to make the hydrogel a hydrophilic phase, and separate the tissue engineered cell sheet by polymer membrane adsorption or clamp clamping method. The obtained cell sheet is cultured in multi-layers or adhered by protein adhesive fluid to obtain a multi-layered cell sheet. The cell sheet obtained by the present invention can maintain the desmosome structure between cells, ZO-1 tight junction structure and other intercellular junction structures, can retain basement membrane protein and many components related to adhesion such as integrin, etc., and also has A certain intensity.
Description
技术领域 technical field
本发明属于组织工程领域,具体涉及一种由温敏性材料-N异丙基丙烯酰胺水凝胶培养得到的组织工程细胞片及其制备方法。The invention belongs to the field of tissue engineering, and in particular relates to a tissue engineering cell sheet cultured by temperature-sensitive material-N isopropylacrylamide hydrogel and a preparation method thereof.
背景技术 Background technique
聚-N异丙基丙烯酰胺(poly(N-isopropylacrylamide),PIPAAm)水凝胶为温度响应性智能聚合物,它在某一温度,也就是通常所说的最低临界溶解温度(lower critical solutiontemperature,LCST)附近存在可逆的不连续的体积相转变,PNIPAAm水凝胶的LCST在32℃左右。这种材料在机械、化学和生物医药等领域具有非常广泛的应用前景。近年来其在组织工程领域的应用越来越受到人们的重视,由于LCST的存在,其用作细胞培养时具有突出的效果。这是因为,当环境温度稍稍高于LCST时,PIPAAm水凝胶体积会突然剧烈收缩,此时是疏水的,将细胞种植在其上,细胞可以黏附生长;当环境温度降到LCST以下时,水凝胶会重新溶胀,此时水凝胶是亲水的,细胞就从它的表面分离。所以我们可以在水凝胶疏水的时候接种细胞,然后进行培养。当细胞增殖到一定的程度时,可以通过降低温度到LCST以下,使水凝胶表面亲水,这样细胞就脱离水凝胶,从而获得整个细胞片,避免了运用酶消化所带来的对细胞的损害,所得细胞片可用于体内移植重建三维组织。Poly-N isopropylacrylamide (poly(N-isopropylacrylamide), PIPAAm) hydrogel is a temperature-responsive intelligent polymer, which has a certain temperature, which is commonly referred to as the lower critical solution temperature (lower critical solution temperature, There is a reversible discontinuous volume phase transition near LCST), and the LCST of PNIPAAm hydrogel is around 32 °C. This material has a very broad application prospect in the fields of machinery, chemistry and biomedicine. In recent years, its application in the field of tissue engineering has attracted more and more attention. Due to the existence of LCST, it has outstanding effects when used in cell culture. This is because, when the ambient temperature is slightly higher than the LCST, the volume of the PIPAAm hydrogel will suddenly shrink sharply. At this time, it is hydrophobic, and the cells can be planted on it, and the cells can adhere and grow; when the ambient temperature drops below the LCST, The hydrogel re-swells, at which point the hydrogel is hydrophilic, and the cells detach from its surface. So we can inoculate the cells when the hydrogel is hydrophobic and then grow them. When the cells proliferate to a certain extent, the surface of the hydrogel can be made hydrophilic by lowering the temperature below the LCST, so that the cells are separated from the hydrogel to obtain the entire cell sheet, avoiding the damage to the cells caused by enzyme digestion. The resulting cell sheet can be used for transplantation in vivo to reconstruct three-dimensional tissue.
PNIPAAm水凝胶的合成方法主要有化学聚合和辐射聚合。化学聚合PIPAAm水凝胶方法已经很成熟,文献已多有报道。化学合成方法制备的温度响应PIPAAm水凝胶因具有以下的缺点而限制了其在组织工程细胞片制备中的应用:(1)化学合成方法,残留物较多,对于后续细胞培养有一定的毒性。(2)化学合成方法不能将PIPAAm水凝胶接枝到聚苯乙烯类培养器皿上,因此,也不能使培养细胞贴壁于PIPAAm水凝胶表面,更不能获得细胞片。辐射聚合是利用电离辐射能来引发有机单体的聚合反应获得高分子化合物。辐射聚合与引发剂引发的聚合反应(即化学聚合)的主要差别是在于引发方式的不同,链反应一经开始,随后的连增长和链终止就与普通方法没有什么区别了。辐射聚合可在进行PNIPAAm单体聚合的同时,将PNIPAAm接枝到普通的聚苯乙烯培养皿或培养板内,用此培养皿或培养板即可培养细胞。辐射聚合按辐射源主要又分为放射性核素、紫外照射和电子加速器引发的聚合。相比于其它两种辐射方式,电子加速器的电子束是定向的,还具有剂量率高、功率大、辐射时间短、处理量大和电子束穿透力低的特点,特别适合制作薄层的PIPAAm温度响应水凝胶培养皿。但是,单纯电子加速器聚合PIPAAm水凝胶时,当总辐射剂量低于240kGy时,不易于形成网络状的聚合物,通常仅形成线性的聚合物,用离子水浸泡后线性聚合物会溶解(图1)。傅里叶红外图谱发现,未加交联剂电子加速器辐射聚合后产生的PIPAAm的图像与线性PIPAAm的图像一致,提示未加交联剂电子加速器辐射聚合后产生的PIPAAm仅表现出线性PIPAAm,未能形成网络状交联的PIPAAm水凝胶(图2)。如果一次采用200kGy以上剂量的电子加速器交联PIPAAm水凝胶,虽然可以获得网络状的聚合物,但高剂量的电子加速伴随瞬间的高温,通常引起聚苯乙烯类的培养器皿变形受损(图3)。The synthesis methods of PNIPAAm hydrogel mainly include chemical polymerization and radiation polymerization. The chemical polymerization method of PIPAAm hydrogel is very mature, and there are many reports in the literature. The temperature-responsive PIPAAm hydrogel prepared by the chemical synthesis method has the following disadvantages that limit its application in the preparation of tissue engineering cell sheets: (1) The chemical synthesis method has many residues and has certain toxicity for subsequent cell culture . (2) The chemical synthesis method cannot graft the PIPAAm hydrogel onto the polystyrene culture vessel, therefore, the cultured cells cannot be attached to the surface of the PIPAAm hydrogel, and cell sheets cannot be obtained. Radiation polymerization is the use of ionizing radiation energy to initiate the polymerization of organic monomers to obtain polymer compounds. The main difference between radiation polymerization and initiator-initiated polymerization (ie, chemical polymerization) lies in the way of initiation. Once the chain reaction starts, the subsequent chain growth and chain termination are no different from ordinary methods. Radiation polymerization can graft PNIPAAm into ordinary polystyrene culture dish or culture plate while carrying out PNIPAAm monomer polymerization, and the culture dish or culture plate can be used for culturing cells. Radiation polymerization is mainly divided into polymerization induced by radionuclide, ultraviolet irradiation and electron accelerator according to the radiation source. Compared with the other two radiation methods, the electron beam of the electron accelerator is directional, and it also has the characteristics of high dose rate, high power, short radiation time, large processing capacity and low electron beam penetration, especially suitable for the production of thin-layer PIPAAm Temperature-responsive hydrogel Petri dishes. However, when the pure electron accelerator polymerizes PIPAAm hydrogel, when the total radiation dose is lower than 240kGy, it is not easy to form a network-like polymer, usually only a linear polymer is formed, and the linear polymer will dissolve after soaking in ionized water (Fig. 1). The Fourier transform infrared spectrum found that the image of PIPAAm produced after electron accelerator radiation polymerization without cross-linking agent was consistent with the image of linear PIPAAm, suggesting that the PIPAAm produced after electron accelerator radiation polymerization without cross-linking agent only showed linear PIPAAm, not A network-like cross-linked PIPAAm hydrogel can be formed (Figure 2). If an electron accelerator with a dose of more than 200kGy is used to cross-link PIPAAm hydrogel, although a network-like polymer can be obtained, high-dose electron acceleration is accompanied by instantaneous high temperature, which usually causes damage to the deformation of polystyrene culture vessels (Fig. 3).
发明内容 Contents of the invention
针对上述现有技术中存在的问题,本发明的目的首先在于提供一种以PIPAAm水凝胶培养得到的组织工程细胞片。In view of the above-mentioned problems in the prior art, the object of the present invention is to provide a tissue engineered cell sheet cultured with PIPAAm hydrogel.
本发明的另一目的是提供上述组织工程细胞片的制备方法。Another object of the present invention is to provide a method for preparing the above-mentioned tissue engineered cell sheet.
上述目的通过以下的技术方案来实现:Above-mentioned purpose is realized through following technical scheme:
一种组织工程细胞片的制备方法,具体包括以下步骤:A method for preparing a tissue engineering cell sheet, specifically comprising the following steps:
(1)在细胞培养支持物表面覆盖含质量浓度为0.1%~1.5%交联剂N,N′-亚甲基双丙烯酰胺的N-异丙基丙烯酰胺单体溶液;所述N-异丙基丙烯酰胺单体的质量浓度为40%~60%。(1) The surface of the cell culture support is covered with a N-isopropylacrylamide monomer solution containing a mass concentration of 0.1% to 1.5% cross-linking agent N, N'-methylenebisacrylamide; the N-isopropylacrylamide The mass concentration of the propylacrylamide monomer is 40%-60%.
(2)对步骤(1)所得溶液进行电子加速器辐射合成,总辐射剂量为240kGy~300kGy,连续分三~六次辐射合成,每次辐射量低于200kGy。得到覆盖了聚N-异丙基丙烯酰胺水凝胶的细胞培养支持物;(2) Perform electron accelerator radiation synthesis on the solution obtained in step (1), the total radiation dose is 240kGy-300kGy, three to six consecutive radiation synthesis times, each time the radiation dose is less than 200kGy. A cell culture support covered with poly-N-isopropylacrylamide hydrogel was obtained;
(3)将步骤(2)得到的细胞培养支持物放到4℃的去离子水中,浸泡5~8天,期间换水4~7次,烤干并灭菌后,密封备用;(3) Put the cell culture support obtained in step (2) into deionized water at 4°C, soak for 5-8 days, change the water 4-7 times during the period, dry and sterilize, and seal it for later use;
(4)控制温度使聚N-异丙基丙烯酰胺水凝胶为疏水相,将细胞接种到步骤(3)得到的细胞培养支持物中,培养细胞;改变温度,使聚N-异丙基丙烯酰胺水凝胶为亲水相,通过高分子膜吸附或夹具钳夹方法,分离出组织工程细胞片。(4) Control the temperature to make the poly-N-isopropylacrylamide hydrogel a hydrophobic phase, inoculate the cells into the cell culture support obtained in step (3), and cultivate the cells; change the temperature to make the poly-N-isopropyl acrylamide The acrylamide hydrogel is a hydrophilic phase, and the tissue engineered cell sheet is separated by polymer membrane adsorption or clamp clamping method.
步骤(1)所述N-异丙基丙烯酰胺单体优选使用经过重结晶的单体。单体的重结晶优选采用体积比为1∶1的苯和异丙醇进行。The N-isopropylacrylamide monomer described in step (1) is preferably a recrystallized monomer. The recrystallization of the monomer is preferably carried out using benzene and isopropanol in a volume ratio of 1:1.
步骤(1)所述N-异丙基丙烯酰胺单体溶液优选采用异丙醇作为溶剂的。用水作为NIPAAm单体溶剂时,溶液不能均匀伸展铺在培养器皿表面,则可能与水是极性溶剂,而异丙醇是非极性溶剂有关。另外,用水作为NIPAAm单体溶剂进行的电离辐射交联效果也不均匀,某些局部效果好,某些部位不能完全交联。因此,以异丙醇为NIPAAm单体溶剂较好。The N-isopropylacrylamide monomer solution in step (1) preferably uses isopropanol as a solvent. When water is used as the NIPAAm monomer solvent, the solution cannot spread evenly on the surface of the culture vessel, which may be related to the fact that water is a polar solvent and isopropanol is a non-polar solvent. In addition, the cross-linking effect of ionizing radiation carried out with water as the NIPAAm monomer solvent is not uniform, some local effects are good, and some parts cannot be completely cross-linked. Therefore, it is better to use isopropanol as the NIPAAm monomer solvent.
步骤(1)所述细胞培养支持物表面的N-异丙基丙烯酰胺单体覆盖量优选为3mg~5mg/cm2。The covering amount of N-isopropylacrylamide monomer on the surface of the cell culture support in step (1) is preferably 3 mg-5 mg/cm 2 .
步骤(1)所述交联剂的加入量优选为10μg~30μg/cm2。The added amount of the cross-linking agent in step (1) is preferably 10 μg-30 μg/cm 2 .
步骤(1)所述细胞培养支持物优选为聚苯乙烯板或者聚四氟乙烯材质,例如聚苯乙烯培养皿(tissue culture polystyrene,TCPS)或六孔板上,或者MILLICELL-CM插入式培养皿(直径:30mm,孔径:0.4μm,聚四氟乙烯(Polytetrafluoroethylene,PTFE)滤膜材料)。The cell culture support in step (1) is preferably a polystyrene plate or a polytetrafluoroethylene material, such as a polystyrene culture dish (tissue culture polystyrene, TCPS) or a six-hole plate, or a MILLICELL-CM insert culture dish (diameter: 30 mm, pore size: 0.4 μm, polytetrafluoroethylene (Polytetrafluoroethylene, PTFE) membrane material).
优选地,步骤(2)所述电子加速器的真空度≤2.2×10-6KPa。Preferably, the vacuum degree of the electron accelerator in step (2) is ≤2.2×10 -6 KPa.
步骤(3)所述灭菌优选采用环氧乙烷灭菌。The sterilization in step (3) is preferably ethylene oxide sterilization.
步骤(4)中利用相转变温度对组织工程细胞片进行分离优选以下方案:In step (4), the phase transition temperature is used to separate the tissue engineered cell sheet, preferably the following scheme:
接种细胞到接枝PIPAAm水凝胶的培养器皿上;置5%CO2培养箱37℃培养,当培养细胞达到80~90%融合时,将培养器皿转移到20℃的孵箱,培养1小时后,细胞成片浮出于溶胀增厚的水凝胶表面,通过高分子膜吸附或夹具钳夹方法,分离出无载体的组织工程细胞片。Inoculate the cells onto the culture vessel grafted with PIPAAm hydrogel; culture in a 5% CO 2 incubator at 37°C, and when the cultured cells reach 80-90% confluence, transfer the culture vessel to an incubator at 20°C and incubate for 1 hour Finally, the cells float in sheets on the surface of the swollen and thickened hydrogel, and the carrier-free tissue engineering cell sheets are separated by polymer membrane adsorption or clamp clamping.
上述细胞的接种适用细胞培养常规的接种方法,例如:取培养中处于指数生长期的细胞,吸取培养液,加入0.25%胰酶-0.02%EDTA,以淹没细胞为宜,置培养箱中(5%CO2,37℃)消化数分钟,当发现贴壁细胞变为圆形时,立即加含血清的培养基终止消化。用吸管吹打成单个细胞悬液,离心。去上清,加入培养液,吹打成单细胞悬液,按所需的浓度,接种到接枝PIPAAm水凝胶的培养器皿上。The inoculation of the above-mentioned cells is suitable for the conventional inoculation method of cell culture, for example: take the cells in the exponential growth phase in the culture, absorb the culture solution, add 0.25% trypsin-0.02% EDTA, it is advisable to submerge the cells, and put them in the incubator (5 %CO 2 , 37°C) for several minutes, when the adherent cells were found to be round, immediately add serum-containing medium to terminate the digestion. Pipette into a single cell suspension and centrifuge. Remove the supernatant, add the culture medium, pipette into a single cell suspension, and inoculate it on the culture vessel grafted with PIPAAm hydrogel according to the required concentration.
本发明当然也提供了上述方法得到的组织工程细胞片,由于从PIPAAm水凝胶表面分离出的生物工程细胞片保留了天然的ECM成分,这些ECM成分具有黏合剂的作用,因此,可以方便地将这些细胞片黏合于需要进行移植治疗的组织器官,无需缝合。Of course, the present invention also provides the tissue engineering cell sheet obtained by the above method, because the bioengineering cell sheet separated from the surface of the PIPAAm hydrogel retains natural ECM components, and these ECM components have the effect of an adhesive, so it can be conveniently These cell sheets are glued to the tissues and organs that need to be transplanted without sutures.
接枝PIPAAm水凝胶的插入式培养皿可以同样进行细胞片的培养,方法同上,另外,可以进行底部培养皿培养饲细胞,PIPAAm水凝胶的插入式培养皿构建细胞片,通过共培养细胞的方法获得活力更好细胞片;PIPAAm水凝胶的插入式培养皿也可以通过气-液培养技术,获得具有分层细胞的上皮细胞片。The inserted culture dish grafted with PIPAAm hydrogel can also be used to culture cell sheets in the same way as above. In addition, feeder cells can be cultured in the bottom culture dish, and the inserted culture dish of PIPAAm hydrogel can be used to construct cell sheets. The cell sheet with better viability can be obtained by the method; the insert culture dish of PIPAAm hydrogel can also obtain the epithelial cell sheet with stratified cells through the air-liquid culture technique.
本发明还提供了一种多层细胞片,该多层细胞片将上述组织工程细胞按常规方法进行多层培养得到的,或者通过黏附蛋白液纵向整合得到;The present invention also provides a multi-layered cell sheet, which is obtained by multi-layered culture of the above-mentioned tissue engineering cells according to a conventional method, or obtained by vertically integrating the adhesive protein solution;
所述黏附蛋白液包括以下蛋白质中至少一种:The adhesive protein liquid includes at least one of the following proteins:
10μg~100μg/ml层粘连蛋白、5μg~50μg/ml纤维连接蛋白、100μg~1mg/ml肽精氨酰-甘氨酰-天冬氨酰-丝氨酸四肽(Arg-Gly-Asp-Ser,RGDS)、100mg~300mg/ml纤维蛋白原,10μg~100μg/mL I型胶原、10μg~100μg/ml IV型胶原;10μg~100μg/ml laminin, 5μg~50μg/ml fibronectin, 100μg~1mg/ml peptide arginyl-glycyl-aspartyl-serine tetrapeptide (Arg-Gly-Asp-Ser, RGDS ), 100mg~300mg/ml fibrinogen, 10μg~100μg/mL type I collagen, 10μg~100μg/ml type IV collagen;
所述胶原用0.006~0.1mol/L乙酸稀释,其它蛋白用pH 8.3的NaHCO3溶液稀释;The collagen is diluted with 0.006-0.1mol/L acetic acid, and other proteins are diluted with NaHCO 3 solution at pH 8.3;
所述纤维蛋白原加入后,需加入等量的凝血酶200~1000U/ml和等量的10%氯化钙液。After the fibrinogen is added, an equal amount of thrombin 200-1000 U/ml and an equal amount of 10% calcium chloride solution need to be added.
相对于现有技术,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1、PNIPAm水凝胶的合成采用结合化学交联和和电子加速器辐射的方法,克服了两种方法单独使用时的缺点。既获得了网络状的PIPAAm水凝胶聚合物以及与聚苯乙烯类的培养器皿接枝的效果,又没有出现培养器皿变形受损,加入极少量的交联剂,合成为聚合物后,通过浸泡处理,残留物极少或无,对于细胞生长基本是无毒性的。1. The synthesis of PNIPAm hydrogel adopts the method of combining chemical cross-linking and electron accelerator radiation, which overcomes the shortcomings of the two methods used alone. It not only obtains the network-like PIPAAm hydrogel polymer and the effect of grafting with polystyrene culture vessels, but also does not cause deformation and damage to the culture vessels. After adding a very small amount of cross-linking agent, it is synthesized into a polymer and passed After immersion treatment, there is little or no residue, and it is basically non-toxic to cell growth.
2、温度响应PIPAAm水凝胶制作的细胞片可以保持细胞与细胞间的桥粒结构、ZO-1紧密连接结构和其它细胞间连接结构,可以保留基底膜蛋白及其与黏合有关的许多成分如整合素等,完整的组织工程细胞片还具有一定的强度。2. The cell sheet made of temperature-responsive PIPAAm hydrogel can maintain the desmosome structure between cells, ZO-1 tight junction structure and other intercellular junction structures, and can retain basement membrane proteins and many components related to adhesion, such as Integrin, etc., the complete tissue engineering cell sheet also has a certain strength.
3、目前多层细胞片都是通过多个单细胞片重叠放置,依靠细胞片自身的粘附蛋白质黏合整合为多层细胞片,但是,在某些情况下,这种重叠放置整合的多层细胞片可能黏合程度不够,易于松散,而应用黏附蛋白液可以弥补这种不足。3. At present, multi-layer cell sheets are placed by overlapping multiple single-cell sheets, relying on the adhesion protein of the cell sheet itself to bond and integrate into a multi-layer cell sheet. However, in some cases, this overlapping and integrated multi-layer The cell sheet may not be cohesive enough and is easy to loosen, and the application of adhesive protein solution can make up for this deficiency.
附图说明 Description of drawings
图1显示了电子加速器聚合PIPAAm水凝胶时,当总辐射剂量低于240kGy时,不易于形成网络状的聚合物,通常仅形成线性的聚合物,用离子水浸泡后线性聚合物会溶解。Figure 1 shows that when the electron accelerator polymerizes PIPAAm hydrogel, when the total radiation dose is lower than 240kGy, it is not easy to form a network polymer, usually only a linear polymer is formed, and the linear polymer will dissolve after soaking in ionized water.
图2为PIPAAm水凝胶傅里叶红外图谱发现:未加交联剂电子加速器辐射聚合后产生的PIPAAm的图像(下方线条)与线性PIPAAm的图像一致(上方线条)。Figure 2 is the Fourier transform infrared spectrum of PIPAAm hydrogel. It is found that the image of PIPAAm (lower line) produced after electron accelerator radiation polymerization without cross-linking agent is consistent with the image of linear PIPAAm (upper line).
图3显示了电子加速器聚合PIPAAm水凝胶时,一次采用200kGy以上剂量的电子加速伴随瞬间的高温,通常引起聚苯乙烯类的培养器皿变形受损,NIPAAm单体未见聚合,变成爆米花状。Figure 3 shows that when the electron accelerator polymerizes PIPAAm hydrogel, a dose of more than 200kGy of electrons is accelerated at a time, accompanied by instantaneous high temperature, which usually causes deformation and damage to the polystyrene culture vessel, and the NIPAAm monomer does not polymerize, turning into popcorn shape.
图4显示了接枝PIPAAm水凝胶的培养器皿在温度高于LCST时的形态。Figure 4 shows the morphology of the culture vessel grafted with PIPAAm hydrogel at a temperature higher than the LCST.
图5显示了接枝PIPAAm水凝胶的培养器皿在温度低于LCST时的形态。Figure 5 shows the morphology of culture dishes grafted with PIPAAm hydrogel at temperatures below the LCST.
图6为加交联剂电子加速器辐射聚合后产生的PIPAAm的傅里叶红外图谱。Fig. 6 is the Fourier transform infrared spectrum of PIPAAm produced after adding cross-linking agent electron accelerator radiation polymerization.
图7为化学方法合成的PIPAAm水凝胶傅里叶红外图谱。Fig. 7 is the Fourier transform infrared spectrum of the PIPAAm hydrogel synthesized by chemical method.
图8为PIPAAm水凝胶的傅里叶红外图谱:其中,上部曲线代表NIPAAm单体经过电子加速器辐射聚合后产生的PIPAAm水凝胶;下部曲线代表化学交联产生的PIPAAm水凝胶。Figure 8 is the Fourier transform infrared spectrum of PIPAAm hydrogel: wherein, the upper curve represents the PIPAAm hydrogel produced by the electron accelerator radiation polymerization of NIPAAm monomer; the lower curve represents the PIPAAm hydrogel produced by chemical crosslinking.
图9为PIPAAm水凝胶原子力显微镜2D图像。Figure 9 is a 2D image of PIPAAm hydrogel atomic force microscope.
图10为PIPAAm水凝胶原子力显微镜3D图像。原子力显微镜检查发现,PIPAAm水凝胶表面形貌有轻微的粗糙。Figure 10 is a 3D image of PIPAAm hydrogel atomic force microscope. Atomic force microscopy revealed that the surface morphology of PIPAAm hydrogel was slightly rough.
图11为PIPAAm水凝胶扫描电子显微镜图像,PIPAAm水凝胶表面致密平滑,未见明显皱褶,水凝胶边缘凹凸粗糙较明显。Figure 11 is a scanning electron microscope image of the PIPAAm hydrogel. The surface of the PIPAAm hydrogel is dense and smooth, without obvious wrinkles, and the rough edges of the hydrogel are more obvious.
图12是NIPAAm单体覆盖量大于5mg/cm2时形成的爆米花状形态。Figure 12 shows the popcorn-like morphology formed when the NIPAAm monomer coverage is greater than 5 mg/cm 2 .
图13是环氧乙烷灭菌器中消毒灭菌后待用的接枝PIPAAm水凝胶的培养器皿。Fig. 13 is the culture vessel of the grafted PIPAAm hydrogel ready for use after being sterilized in an ethylene oxide sterilizer.
图14是酶消化组织块进行细胞分离培养的角膜上皮细胞第5天的倒置显微镜下的图像,可见组织块残留。Fig. 14 is an image under an inverted microscope on day 5 of the corneal epithelial cells cultured by enzymatically digesting the tissue block for cell isolation, and the tissue block remains.
图15是角膜上皮细胞培养9天的倒置显微镜下的图像,可见融合成片的角膜上皮细胞及其边缘结构。Fig. 15 is an image under an inverted microscope of corneal epithelial cells cultured for 9 days, and the fused corneal epithelial cells and their edge structures can be seen.
图16是在PIPAAm水凝胶表面贴壁生长的口腔黏膜上皮细胞。Figure 16 is oral mucosal epithelial cells growing adherently on the surface of PIPAAm hydrogel.
图17是在PIPAAm水凝胶表面贴壁生长的角膜基质细胞。Figure 17 shows the corneal stromal cells growing adherently on the surface of PIPAAm hydrogel.
图18是在PIPAAm水凝胶表面边缘贴壁生长的角膜基质细胞,显示整齐的角膜基质细胞片边缘结构。Figure 18 shows the corneal stromal cells growing adherently on the edge of the surface of the PIPAAm hydrogel, showing the orderly edge structure of the corneal stromal cell sheet.
图19是无载体的含复层细胞的单片角膜基质细胞片的H&E染色的组织切片图像。Figure 19 is an H&E stained histological section image of a single corneal stromal cell sheet containing stratified cells without a carrier.
图20是单片角膜基质细胞片的扫描电子显微镜图像,显示出细胞排列紧密的表面结构。Figure 20 is a scanning electron microscope image of a single corneal stromal cell sheet, showing a densely packed surface structure.
图21是单片角膜基质细胞片的扫描电子显微镜图像,显示出角膜基质细胞片的边缘结构。Figure 21 is a scanning electron microscope image of a single corneal stromal cell sheet showing the edge structure of the corneal stromal cell sheet.
图22是在PIPAAm水凝胶表面贴壁生长的3T3细胞。Figure 22 shows 3T3 cells growing adherently on the surface of PIPAAm hydrogel.
图23是无载体的两片复合角膜基质细胞片的H&E染色的组织切片图像。Figure 23 is an H&E stained histological section image of two composite keratocyte stromal cell sheets without carrier.
图24是多片复合角膜基质细胞片的扫描电子显微镜图像,显示出细胞排列紧密的表面结构。Figure 24 is a scanning electron microscope image of multiple composite corneal stromal cell sheets, showing a densely packed surface structure.
图25是无载体的多片复合角膜基质细胞片形成早期的H&E染色的组织切片图像,每个细胞片之间粘合不够紧密。Figure 25 is an H&E-stained tissue section image of multiple composite corneal stromal cell sheets without a carrier in the early stage of formation, and the adhesion between each cell sheet is not tight enough.
图26是无载体的多片复合角膜基质细胞片形成的H&E染色的组织切片图像,每个细胞片之间粘合紧密,形成完整的7-10层角膜基质细胞片。Figure 26 is an image of H&E stained tissue sections formed by multiple composite corneal stromal cell sheets without a carrier, and each cell sheet is tightly bonded to form a complete 7-10-layer corneal stromal cell sheet.
具体实施方式 Detailed ways
下面结合实施例,对本发明做进一步地详细说明,但本发明的实现方式并不局限于此。The present invention will be described in further detail below in conjunction with the embodiments, but the implementation of the present invention is not limited thereto.
实施例1角膜上皮细胞片的构建
1、PNIPAm水凝胶接枝培养皿的制备1. Preparation of PNIPAm hydrogel grafted culture dish
(1)重结晶单体(1) Recrystallized monomer
将购买来的N-异丙基丙烯酰胺单体(N-isopropylacrylamide,NIPAAm)(上海物竞科技有限公司),运用体积比为1∶1的苯和异丙醇进行重结晶,重结晶后的NIPAAm单体干燥后待用。The purchased N-isopropylacrylamide monomer (N-isopropylacrylamide, NIPAAm) (Shanghai Wujing Technology Co., Ltd.) was recrystallized using benzene and isopropanol at a volume ratio of 1:1, and the recrystallized The NIPAAm monomer was dried for use.
(2)配制单体溶液(2) Preparation of monomer solution
配制质量浓度为40%的NIPAAm单体溶液,含质量浓度为0.1%交联剂N,N′-亚甲基双丙烯酰胺(N,N-methylene bisacrylamide,MBA),以上均为通过溶液异丙醇配制,震荡混匀后待用。Prepare a NIPAAm monomer solution with a mass concentration of 40%, containing a mass concentration of 0.1% cross-linking agent N, N'-methylene bisacrylamide (N, N-methylene bisacrylamide, MBA), all of which are passed through the solution isopropyl Alcohol preparation, shake and mix well before use.
(3)辐射合成单体溶液(3) Radiation Synthesis of Monomer Solution
取上述已配制好的NIPAAm单体溶液,加入到35mm的聚苯乙烯板(tissue culturepolystyrene,TCPS)培养皿上,通过单体溶液自身的张力而均匀伸展铺在培养器皿表面。单体在培养器皿表面的覆盖量为4mg/cm2。将其放到电子加速器(地那米加速器,中科院上海原子核研究所制造)的小车上进行电子辐射合成,电子加速器辐射合成时的数据是:辐射剂量为240kgy,用小车连续分三次辐射合成,电子加速器真空度为2.2×10-6KPa。经过电子加速器辐射作用,使NIPAAm单体聚合为PIPAAm水凝胶,与此同时,NIPAAm单体与培养器皿接枝聚合。Take the above-prepared NIPAAm monomer solution, add it to a 35mm tissue culture polystyrene (TCPS) culture dish, and spread it evenly on the surface of the culture vessel through the tension of the monomer solution itself. The covering amount of the monomer on the surface of the culture vessel is 4 mg/cm 2 . Put it on the trolley of electron accelerator (Dinamic accelerator, manufactured by Shanghai Institute of Nuclear Research, Chinese Academy of Sciences) and carry out electron radiation synthesis. The data during electron accelerator radiation synthesis is: the radiation dose is 240kgy. The accelerator vacuum is 2.2×10 -6 KPa. After electron accelerator radiation, the NIPAAm monomer is polymerized into PIPAAm hydrogel, and at the same time, the NIPAAm monomer is grafted and polymerized with the culture vessel.
本实施例接枝的PIPAAm水凝胶具有温度响应特点:当温度高于LCST时,体积收缩,变为乳白色薄层(图4),当温度低于LCST时,体积溶胀,变为透明的水凝胶(图5)。PIPAAm水凝胶傅里叶红外图谱发现,在1644cm-1附近出现的谱带是由酰胺的羧基伸缩振动产生的,即酰胺I带;而在1538cm-1处的谱带为酰胺II带,是由酰胺基团中的N-H弯曲振动和C-H伸缩振动的组合吸收产生的。另外,波数在1386cm-1和1367cm-1附近都出现了吸收峰,这是NIPAAm的异丙基-CH(CH3)2中对称C-H振动的特征谱。加入少量交联剂后的PIPAAm水凝胶傅里叶红外图谱图像与化学合成的主要成分图像一致,提示NIPAAm单体经过电子加速器辐射聚合后产生的PIPAAm水凝胶成分与化学交联产生的PIPAAm水凝胶主要成分相近(图6,图7,图8)。Autoprobe CP Research型原子力显微镜(美国THERMO公司)检查发现,PIPAAm水凝胶表面形貌有轻微的粗糙(图9,图10)。JEOLT-300SEM扫描电子显微镜(日本电子株式会社)检查进一步证实,PIPAAm水凝胶表面致密平滑,未见明显皱褶,水凝胶边缘凹凸粗糙较明显(图11)。单体在培养器皿表面的覆盖量为3mg~5mg/cm2,覆盖量少于3mg/cm2时,不能辐射聚合为成片状的PIPAAm水凝胶;覆盖量大于5mg/cm2时,容易形成爆米花样,并不能形成薄层的PIPAAm水凝胶(图12)。另外,培养细胞也难以贴附于其上。培养细胞贴附在PIPAAm水凝胶表面的生长是与细胞的黏附蛋白(例如纤维连接蛋白)吸附于水凝胶相关的,如果单体覆盖量太大,形成厚层的PIPAAm水凝胶,难以吸附纤维连接蛋白等成分。MBA加入量一般为10μg~30μg/cm2,MBA过少交联少或仅形成线性交联,吸水后松散;MBA过大交联度太大,失去吸水特性。The PIPAAm hydrogel grafted in this embodiment has temperature response characteristics: when the temperature is higher than the LCST, the volume shrinks and becomes a milky white thin layer (Figure 4), and when the temperature is lower than the LCST, the volume swells and becomes transparent water gel (Figure 5). The Fourier transform infrared spectrum of PIPAAm hydrogel found that the band appearing near 1644cm-1 is produced by the carboxyl stretching vibration of amide, that is, the amide I band; while the band at 1538cm-1 is the amide II band, which is resulting from the combined absorption of NH bending vibrations and CH stretching vibrations in the amide group. In addition, there are absorption peaks around 1386cm-1 and 1367cm-1, which is the characteristic spectrum of symmetrical CH vibration in isopropyl-CH(CH 3 ) 2 of NIPAAm. The Fourier transform infrared spectrum image of PIPAAm hydrogel after adding a small amount of cross-linking agent is consistent with the main component image of chemical synthesis, suggesting that the PIPAAm hydrogel component produced by the electron accelerator radiation polymerization of NIPAAm monomer is the same as the PIPAAm produced by chemical crosslinking. The main components of the hydrogels are similar (Fig. 6, Fig. 7, Fig. 8). Autoprobe CP Research Atomic Force Microscope (Thermo Company, USA) found that the surface morphology of PIPAAm hydrogel was slightly rough (Fig. 9, Fig. 10). The JEOLT-300SEM scanning electron microscope (Japan Electronics Co., Ltd.) further confirmed that the surface of the PIPAAm hydrogel was dense and smooth, with no obvious wrinkles, and the rough edges of the hydrogel were obvious (Figure 11). The coverage of the monomer on the surface of the culture vessel is 3mg-5mg/cm 2 , when the coverage is less than 3mg/cm 2 , it cannot be radiated and polymerized into sheet-like PIPAAm hydrogel; when the coverage is greater than 5mg/cm 2 , it is easy A popcorn-like appearance was formed, and a thin layer of PIPAAm hydrogel was not formed (FIG. 12). In addition, it is difficult for cultured cells to attach thereto. The growth of cultured cells attached to the surface of PIPAAm hydrogel is related to the adsorption of cell adhesion proteins (such as fibronectin) to the hydrogel. If the monomer coverage is too large, a thick layer of PIPAAm hydrogel is formed, which is difficult to Adsorbs components such as fibronectin. The amount of MBA added is generally 10μg-30μg/cm 2 , too little MBA has little crosslinking or only linear crosslinking, and loosens after absorbing water; too much MBA has too much crosslinking degree and loses water absorption characteristics.
用水作为NIPAAm单体溶剂时,溶液不能均匀伸展铺在培养器皿表面,则可能与水是极性溶剂,而异丙醇是非极性溶剂有关。另外,用水作为NIPAAm单体溶剂进行的电离辐射交联效果也不均匀,某些局部效果好,某些部位不能完全交联。因此,以异丙醇为NIPAAm单体溶剂较好。When water is used as the NIPAAm monomer solvent, the solution cannot spread evenly on the surface of the culture vessel, which may be related to the fact that water is a polar solvent and isopropanol is a non-polar solvent. In addition, the cross-linking effect of ionizing radiation carried out with water as the NIPAAm monomer solvent is not uniform, some local effects are good, and some parts cannot be completely cross-linked. Therefore, it is better to use isopropanol as the NIPAAm monomer solvent.
(4)辐射合成后的PIPAAm水凝胶的处理(4) Processing of PIPAAm hydrogel after radiation synthesis
将辐射合成后的温敏水凝胶放到4℃的去离子水中,浸泡5天,期间换水4次,放入50℃烤箱中烤干。接枝PIPAAm水凝胶的培养器皿通过封口机将纸塑包装封口,封口之前放一张环氧乙烷灭菌指示试纸,将其放到HM-23环氧乙烷灭菌器(沈阳德龙电子有限公司)中消毒灭菌,当试纸由红色变为蓝色,表示灭菌消毒达标,取出后待用,进行细胞培养时再拆封使用(图13)。Put the temperature-sensitive hydrogel synthesized by radiation into deionized water at 4°C, soak for 5 days, change the
2、水凝胶上的细胞培养和移植2. Cell culture and transplantation on hydrogel
(1)培养液(1) culture medium
培养液:A.添加激素的上皮细胞培养液(supplemental hormonal epithelial medium,SHEM):DMEM/F12(3∶1),10μg/L表皮生长因子、1000U/L胰岛素、0.1mg/L霍乱毒素、0.18mM/L腺嘌呤、0.5mg/L氢化可的松、1.2g/L NaHCO3、10%胎牛血清(FBS)、10万U/L青霉素和100mg/L链霉素。B.低钙角质形成细胞培养基(keratinocyte serum freemedium,KSFM),Ca2+的浓度为0.07mM~0.09mM。培养试剂除特别说明外,采用美国Gibco公司产品。其他化学试剂除除特别说明外,采用美国Sigma公司产品。Culture medium: A. Supplemental hormonal epithelial medium (SHEM): DMEM/F12 (3:1), 10 μg/L epidermal growth factor, 1000 U/L insulin, 0.1 mg/L cholera toxin, 0.18 mM/L adenine, 0.5mg/L hydrocortisone, 1.2g/L NaHCO3, 10% fetal bovine serum (FBS), 100,000 U/L penicillin and 100mg/L streptomycin. B. Low-calcium keratinocyte medium (keratinocyte serum freemedium, KSFM), the concentration of Ca 2+ is 0.07mM-0.09mM. Unless otherwise specified, the culture reagents were the products of Gibco, USA. Unless otherwise specified, other chemical reagents used the products of Sigma Company in the United States.
(3)取材(3) Take materials
尽可能地在灭菌条件下使用灭菌的器具进行相关操作。离体眼球取材:分离宽约2mm的角膜缘环形组织,将其平均剪为8片。自体活体眼球取材:浅层分离角膜缘约2×3×1mm3。As much as possible, use sterilized instruments under sterile conditions for related operations. Extraction of isolated eyeballs: Separate the limbal ring tissue with a width of about 2 mm, and cut it into 8 pieces on average. Autologous living eyeball material: The superficial separation of the limbus is about 2×3×1mm 3 .
(4)酶消化组织块进行细胞分离(4) Enzymatic digestion of tissue blocks for cell separation
将上述角膜缘组织小块置4℃无血清含1.2U/ml中性蛋白酶和100mM山梨醇的角膜上皮细胞培养液中,约10小时,解剖显微镜下,将松动的上皮层用显微镊子分离。置于15ml离心管,离心管内加入约5ml胰蛋白酶液(0.05%胰蛋白酶和0.02%EDTA),37℃下消化30分钟,终止消化后置1000rpm/min离心,5分钟。离心后吸走上清液,加入10%胎牛血清,DMEM/F12培养液吹打,制成细胞悬液,以2×104/ml细胞数接种,进行细胞原代培养。DM/L倒置生物显微镜(德国徕卡公司)下检查发现酶消化组织块进行细胞分离培养的角膜上皮以及融合成片的角膜上皮细胞(图14,图15)。以1×105/ml细胞密度接种于培养器皿进行传代细胞培养,使用培养5代内的传代细胞。Put the above small pieces of limbal tissue in the corneal epithelial cell culture medium without serum containing 1.2U/ml neutral protease and 100mM sorbitol at 4°C for about 10 hours. Under a dissecting microscope, separate the loose epithelial layer with micro tweezers . Place in a 15ml centrifuge tube, add about 5ml trypsin solution (0.05% trypsin and 0.02% EDTA) into the centrifuge tube, digest at 37°C for 30 minutes, and centrifuge at 1000rpm/min for 5 minutes after the digestion is terminated. After centrifugation, the supernatant was sucked away, 10% fetal bovine serum was added, and the DMEM/F12 culture medium was pipetted to make a cell suspension, which was inoculated at a cell number of 2×10 4 /ml for primary cell culture. Under the DM/L inverted biological microscope (Leica, Germany), it was found that the corneal epithelium and the corneal epithelial cells fused into sheets were digested with enzymes for cell isolation and cultured (Fig. 14, Fig. 15). Inoculate the culture vessel at a cell density of 1×10 5 /ml for subculture, and use the subculture within 5 passages.
(5)复层细胞的角膜上皮细胞片(5) Corneal epithelial cell sheets of stratified cells
将培养的角膜缘上皮细胞以2×104/ml的细胞密度接种于步骤1得到的所述培养皿表面,进行单细胞培养。The cultured limbal epithelial cells were seeded on the surface of the culture dish obtained in
(6)角膜上皮细胞片的分离获取(6) Separation and acquisition of corneal epithelial cell sheets
采用硝酸纤维膜粘附细胞片直接分离。Adhesive cell sheets were isolated directly using nitrocellulose membranes.
(7)角膜上皮细胞片移植(7) Corneal epithelial cell sheet transplantation
移植对象:(1)实验动物:对新西兰白兔或其它动物,自距角膜缘外4mm处,用弯剪刀除去约0.1~1mm的角膜上皮及结膜上皮,制作眼表面干细胞缺乏症动物模型,用荧光素眼表染色确认角膜上皮细胞完全去除。4周后,该动物眼表面被周围残存的结膜上皮所覆盖,出现角膜表面混浊和角膜新生血管。(2)临床患者:包括化学伤急性期的迁延性角膜上皮缺损患者、化学伤慢性期的疤痕组织侵入引起角膜新生血管和角膜混浊的患者、角膜缘干细胞缺乏的眼表疾病、角膜缘功能障碍等角膜病变、眼类天疱疮等患者。移植的没有任何生物材料的角膜上皮细胞片可以用于各种角膜疾病的治疗,这样就有望很好的解决因为生物材料的降解或体内组织与生物材料的作用而出现的各种术后反应。采用自体的健康角膜上皮细胞进行培养可以获得自体角膜上皮细胞片,将其进行移植可以解决角膜供体不足的矛盾以及去除异体角膜上皮细胞片移植出现的术后排斥反应。Transplanted objects: (1) Experimental animals: For New Zealand white rabbits or other animals, use curved scissors to remove about 0.1-1 mm of corneal epithelium and conjunctival epithelium from a
手术方法:将病变角膜全浅层板层分离切除,去除混浊、结膜上皮化和新生血管化的角膜表面组织,充分止血和清洗,暴露透明的角膜基质,制作出受体植床。将上述与硝酸纤维膜粘附的功能活性人工角膜上皮片与植床接触贴附,通过细胞片黏附蛋白与角膜基质之间的组织黏合,达到细胞片移植,移植后去除硝酸纤维膜。必要时可以使用绷带型角膜接触镜保护移植的细胞片。术后,局部使用抗生素滴眼液及眼膏,2次/日。角膜上皮细胞片移植体内后,应用荧光素染色检查移植的角膜上皮细胞片是否具有屏障机能,确认上皮细胞片的移植效果。Surgical method: The entire superficial layer of the diseased cornea is separated and resected, the turbidity, conjunctival epithelialization and neovascularization of the corneal surface tissue are removed, the bleeding is fully stopped and cleaned, the transparent corneal stroma is exposed, and a recipient implant bed is made. The above-mentioned functionally active artificial corneal epithelium sheet adhered to the nitrocellulose membrane is contacted and attached to the implantation bed, and the cell sheet transplantation is achieved through the tissue adhesion between the cell sheet adhesion protein and the corneal stroma, and the nitrocellulose membrane is removed after transplantation. If necessary, a bandage-type contact lens can be used to protect the transplanted cell sheet. After the operation, antibiotic eye drops and eye ointment were used locally, 2 times a day. After the corneal epithelial cell sheet is transplanted into the body, fluorescein staining is used to check whether the transplanted corneal epithelial cell sheet has a barrier function, and to confirm the transplantation effect of the epithelial cell sheet.
上述角膜上皮细胞片的构建和移植的种子细胞除了应用角膜缘上皮细胞,也可以应用口腔粘膜上皮细胞(图16)和其它细胞。当难以获得健康的自体角膜缘上皮细胞时,可以应用自体的口腔粘膜上皮细胞和其它细胞作为替代种子细胞,同样具有解决角膜供体不足的矛盾以及减少异体角膜上皮细胞片移植出现的术后排斥反应的优点。In addition to limbal epithelial cells, oral mucosal epithelial cells ( FIG. 16 ) and other cells can also be used as seed cells for the above-mentioned construction of the corneal epithelial cell sheet and transplantation. When it is difficult to obtain healthy autologous corneal limbal epithelial cells, autologous oral mucosal epithelial cells and other cells can be used as substitute seed cells, which can also solve the contradiction of insufficient corneal donors and reduce postoperative rejection of allogeneic corneal epithelial cell sheet transplantation Advantages of the response.
实施例2角膜上皮细胞片的构建
1、PNIPAm水凝胶接枝培养皿的制备1. Preparation of PNIPAm hydrogel grafted culture dish
(1)重结晶单体(1) Recrystallized monomer
同实施例1。With
(2)配制单体溶液(2) Preparation of monomer solution
配制质量浓度为60%的NIPAAm单体溶液,含质量浓度为0.4%交联剂N,N′-亚甲基双丙烯酰胺(N,N-methylene bisacrylamide,MBA),以上均为通过溶液异丙醇配制,震荡混匀后待用。Prepare a NIPAAm monomer solution with a mass concentration of 60%, containing a mass concentration of 0.4% cross-linking agent N, N'-methylene bisacrylamide (N, N-methylene bisacrylamide, MBA), all of which are passed through the solution isopropyl Alcohol preparation, shake and mix well before use.
(3)辐射合成单体溶液(3) Radiation Synthesis of Monomer Solution
取上述已配制好的NIPAAm单体溶液,加入到MILLICELL-CM插入式培养皿[直径:30mm,孔径:0.4μm,聚四氟乙烯(Polytetrafluoroethylene,PTFE)(Millipore公司,美国)滤膜材料]表面上,通过单体溶液自身的张力而均匀伸展铺在培养器皿表面。单体在培养器皿表面的覆盖量为4.5mg/cm2。将其放到电子加速器的小车上进行电子辐射合成,电子加速器辐射合成时的数据是:辐射剂量为300kgy,用小车连续分六次辐射合成,电子加速器真空度为2.2×10-6KPa。经过电子加速器辐射作用,使NIPAAm单体聚合为PIPAAm水凝胶,与此同时,NIPAAm单体与培养器皿接枝聚合。Take the above prepared NIPAAm monomer solution and add it to the surface of the MILLICELL-CM insert culture dish [diameter: 30mm, pore size: 0.4μm, polytetrafluoroethylene (PTFE) (Millipore Company, USA) membrane material] On the surface of the culture vessel, it is spread evenly on the surface of the culture vessel by the tension of the monomer solution itself. The coverage of the monomer on the surface of the culture vessel was 4.5 mg/cm 2 . Put it on the trolley of the electron accelerator for electron radiation synthesis. The data of the electron accelerator radiation synthesis is: the radiation dose is 300kgy, and the trolley is used for six consecutive radiation synthesis, and the vacuum degree of the electron accelerator is 2.2×10 -6 KPa. After electron accelerator radiation, the NIPAAm monomer is polymerized into PIPAAm hydrogel, and at the same time, the NIPAAm monomer is grafted and polymerized with the culture vessel.
得到的接枝的PIPAAm水凝胶与实施例得到的水凝胶具有相类似的特点。The obtained grafted PIPAAm hydrogel has similar characteristics to the hydrogel obtained in the examples.
(4)辐射合成后的PIPAAm水凝胶的处理(4) Processing of PIPAAm hydrogel after radiation synthesis
将辐射合成后的温敏水凝胶放到4℃的去离子水中,浸泡8天,期间换水7次,放入50℃烤箱中烤干。此后的处理同实施例1。The temperature-sensitive hydrogel synthesized by radiation was placed in deionized water at 4°C, soaked for 8 days, and the water was changed 7 times during the period, and dried in an oven at 50°C. The subsequent processing is the same as in Example 1.
2、水凝胶上的细胞培养和移植2. Cell culture and transplantation on hydrogel
(1)培养液(1) culture medium
同实施例1。With
(3)取材(3) Take materials
同实施例1。With
(4)酶消化组织块进行细胞分离(4) Enzymatic digestion of tissue blocks for cell separation
将上述角膜缘组织小块置4℃无血清含2.4U/ml中性蛋白酶和100mM山梨醇的角膜上皮细胞培养液中,约18小时,解剖显微镜下,将松动的上皮层用显微镊子分离。置于15ml离心管,离心管内加入约5ml胰蛋白酶液(0.05%胰蛋白酶和0.02%EDTA),37℃下消化30分钟,终止消化后置1000rpm/min离心,5分钟。离心后吸走上清液,加入10%胎牛血清,DMEM/F12培养液吹打,制成细胞悬液,以1×106/ml细胞数接种,进行细胞原代培养。以1×106/ml细胞密度接种于培养器皿进行传代细胞培养,使用培养5代内的传代细胞。Place the above-mentioned small pieces of limbal tissue in corneal epithelial cell culture medium containing 2.4 U/ml neutral protease and 100 mM sorbitol without serum at 4°C for about 18 hours. Under a dissecting microscope, separate the loose epithelial layer with micro tweezers . Place in a 15ml centrifuge tube, add about 5ml trypsin solution (0.05% trypsin and 0.02% EDTA) into the centrifuge tube, digest at 37°C for 30 minutes, and centrifuge at 1000rpm/min for 5 minutes after the digestion is terminated. After centrifugation, the supernatant was sucked away, 10% fetal bovine serum was added, and the DMEM/F12 culture medium was pipetted to make a cell suspension, which was inoculated at a cell number of 1×10 6 /ml for primary cell culture. Inoculate the culture vessel at a cell density of 1×10 6 /ml for subculture, and use the subculture within 5 passages.
(5)复层细胞的角膜上皮细胞片(5) Corneal epithelial cell sheets of stratified cells
将培养的角膜缘上皮细胞以1×106/ml的细胞密度接种于步骤1得到的插入式培养皿表面,进行细胞共培养:预先将培养融合的3T3成纤维细胞或人胚胎成纤维细胞与4μg/mL的丝裂霉素C共孵育2小时,PBS洗涤2次,胰酶消化后,以1×104/cm2接种培养皿或培养板内。其后才在此培养皿或培养板内放入含角膜缘上皮细胞的插入式培养皿。放入5%的CO2培养箱中37℃培养,97%湿度,每2~3天换液1次,常规培养7~10天后,进行气液培养,即减少培养液加入量,加培养液平面仅达插入式培养皿表面,使培养的上皮细胞表面更多接触空气,每周加已用丝裂霉素处理的饲细胞,气液培养7~10天后获得复层角膜上皮细胞片。The cultured limbal epithelial cells were inoculated on the surface of the insert culture dish obtained in
(6)角膜上皮细胞片的分离获取(6) Separation and acquisition of corneal epithelial cell sheets
获取复层角膜上皮片的方法为:在上述复层角膜上皮细胞片培养完成后,减少插入式培养皿内培养液,在培养细胞上覆盖硝酸纤维膜,放入培养箱20℃培养30分钟,在20℃以下温度条件下,将黏合整张细胞片的硝酸纤维膜从亲水性的疏松线团结构的PIPAAm剥离。The method for obtaining the stratified corneal epithelial sheet is as follows: after the above-mentioned stratified corneal epithelial cell sheet is cultured, reduce the culture medium in the insert culture dish, cover the cultured cells with a nitrocellulose membrane, and put them in an incubator at 20°C for 30 minutes. At a temperature below 20°C, the nitrocellulose membrane that adhered to the entire cell sheet was peeled off from the hydrophilic PIPAAm with a loose coil structure.
(7)角膜上皮细胞片移植(7) Corneal epithelial cell sheet transplantation
可用与实施例相同的方法将细胞片进行移植。Cell sheets can be transplanted in the same manner as in Examples.
实施例3角膜内皮细胞片Example 3 Corneal endothelial cell sheet
按角膜内皮细胞常规培养方法进行种子细胞培养,采用实施例1或2所述角膜上皮细胞片构建类似的方法构建角膜内皮细胞片。角膜内皮细胞片移植可以治疗角膜内皮细胞病变和内皮细胞功能失代偿等患者:去除病变的角膜后板层及角膜内皮层,通过类似于穿透性角膜移植、深板层角膜内皮移植和后弹力层剥除角膜内皮移植等手术方法进行角膜内皮细胞片移植。角膜内皮细胞片移植通常不需要缝线缝合,采用细胞片黏附蛋白与角膜后板层之间的组织黏合,达到细胞片移植。或采用上述至少一种的黏附蛋白液将细胞片黏附到角膜后板层。裂隙灯观察角膜透明情况,检查是否出现角膜水肿,确认角膜内皮细胞片移植效果。上述角膜内皮细胞片的构建和移植的种子细胞除了应用角膜内皮细胞,也可以应用其它细胞。The seed cell culture was carried out according to the conventional culture method of corneal endothelial cells, and the corneal endothelial cell sheet was constructed by a method similar to the construction of the corneal epithelial cell sheet described in Example 1 or 2. Corneal endothelial cell sheet transplantation can treat patients with corneal endothelial cell lesions and endothelial cell function decompensation: remove the diseased corneal posterior lamellar and corneal endothelial layer, through similar penetrating keratoplasty, deep lamellar corneal endothelial Corneal endothelial cell sheet transplantation is performed by surgical methods such as elastic membrane stripping and corneal endothelial transplantation. Corneal endothelial cell sheet transplantation usually does not require sutures, and the tissue adhesion between the cell sheet adhesion protein and the posterior corneal lamina is used to achieve cell sheet transplantation. Or use at least one of the above adhesive protein solutions to adhere the cell sheet to the posterior corneal lamina. Slit lamp observation of corneal transparency, check whether there is corneal edema, and confirm the effect of corneal endothelial cell sheet transplantation. In addition to using corneal endothelial cells as the seed cells for the above-mentioned construction of the corneal endothelial cell sheet and transplantation, other cells can also be used.
实施例4角膜基质细胞片Example 4 Corneal stromal cell sheet
按角膜基质细胞常规培养方法进行种子细胞培养,采用上述角膜上皮细胞片构建类似的方法构建角膜基质细胞片(图17,图18)),通过上述方法降低温度分离可获取无载体的角膜基质细胞片。角膜基质细胞片的H&E染色的组织切片在光学显微镜下组织学检查发现,无载体单片角膜基质细胞片内细胞排列紧密,含2-3层的复层细胞结构(图19)。扫描电子显微镜下检查发现单片角膜基质细胞片细胞排列紧密的表面结构(图20)和边缘结构(图21)。角膜基质细胞片移植可以治疗角膜病变患者:去除角膜基质层病变组织,通过类似于板层角膜移植手术方法进行角膜基质细胞片移植,角膜基质细胞片移植通常不需要缝线缝合,采用细胞片黏附蛋白与角膜之间的组织黏合,达到细胞片移植。或采用上述至少一种的黏附蛋白液将细胞片黏附到角膜组织。裂隙灯观察角膜情况,确认角膜基质细胞片移植效果。上述角膜基质细胞片的构建和移植的种子细胞除了应用角膜基质细胞,也可以应用其它细胞(图22)。Carry out seed cell culture according to the conventional culture method of corneal stromal cells, and use the above-mentioned corneal epithelial cell sheet to construct a similar method to construct corneal stromal cell sheet (Figure 17, Figure 18)), and reduce the temperature separation by the above method to obtain carrier-free corneal stromal cells piece. The histological examination of the H&E stained tissue section of the corneal stromal cell sheet under an optical microscope revealed that the cells in the carrier-free single corneal stromal cell sheet were tightly arranged and contained 2-3 layers of stratified cell structure (Figure 19). Examination under the scanning electron microscope revealed that the surface structure (Figure 20) and the edge structure (Figure 21) of the monolithic corneal stromal cell sheet cells were tightly arranged. Corneal stromal cell sheet transplantation can treat patients with keratopathy: remove the corneal stromal layer lesion tissue, and perform corneal stromal cell sheet transplantation through a method similar to lamellar keratoplasty. Corneal stromal cell sheet transplantation usually does not require sutures, and cell sheet adhesion is used The tissue adhesion between the protein and the cornea achieves cell sheet transplantation. Or use at least one of the above adhesive protein solutions to adhere the cell sheet to the corneal tissue. Slit lamp observation of the cornea to confirm the effect of corneal stromal cell sheet transplantation. In addition to corneal stromal cells, other cells can also be used as the seed cells for the construction and transplantation of the corneal stromal cell sheet ( FIG. 22 ).
实施例5多片复合角膜基质细胞片的制备Example 5 Preparation of Multiple Composite Corneal Stromal Cell Sheets
按角膜基质细胞常规培养方法进行种子细胞培养,采用上述角膜上皮细胞片构建类似的方法构建单片角膜基质细胞片,采用上述细胞片分离获取的方法获取多个单片角膜基质细胞片。按照以下单片重叠放置整合多片培养方法获得多片复合角膜基质细胞片:采用上述角膜基质细胞片构建类似的方法构建角膜基质细胞片后,减少培养器皿的培养液至培养器皿的底部,将上述多个单片角膜基质细胞片逐片纵向重叠放置整合为多层细胞片,防止细胞片卷曲和脱离,静置数分钟至数小时后,加入足够的培养液,常规培养数小时至数日。采用上述细胞片分离获取的方法获取一个多片复合角膜基质细胞片,制作出可移植的两片(图23)或多片复合角膜基质细胞片(图24)。多片复合角膜基质细胞片形成早期,每个细胞片之间粘合不够紧密(图25),放置数小时至数日培养后,每个细胞片之间粘合紧密,可以形成完整的7-10层角膜基质细胞片(图26)。由于从PIPAAm水凝胶表面分离出的单片角膜基质细胞片保留了天然的ECM蛋白成分,这些ECM蛋白具有黏合剂的作用,因此,单片重叠放置整合多片培养方法可以获得细胞结构紧密完整的多片复合角膜基质细胞片。多片复合角膜基质细胞片的移植方法同实施例4。The seed cell culture was carried out according to the conventional culture method of corneal stromal cells, and a single corneal stromal cell sheet was constructed by a method similar to the construction of the above corneal epithelial cell sheet, and multiple single corneal stromal cell sheets were obtained by the above method of separating and obtaining the cell sheet. Obtain multiple composite keratocyte stromal cell sheets according to the following method of stacking single sheets and integrating multiple sheets of culture: after constructing keratocyte stromal cell sheets using a method similar to the above-mentioned keratocyte stromal cell sheet construction, reduce the culture medium of the culture vessel to the bottom of the culture vessel, and place The above-mentioned multiple single corneal stromal cell sheets are stacked vertically one by one and integrated into a multi-layered cell sheet to prevent the cell sheet from curling and detachment. After standing for several minutes to several hours, add enough culture medium and perform routine culture for several hours to several days. . Using the above cell sheet separation and acquisition method to obtain a multi-sheet composite keratocyte stromal cell sheet, and make two (Fig. 23) or multiple composite keratoma stromal cell sheets (Fig. 24) that can be transplanted. In the early stage of multi-composite corneal stromal cell sheets, the adhesion between each cell sheet is not tight enough (Figure 25). 10-layer corneal stromal cell sheet (Fig. 26). Since the single piece of corneal stromal cell sheet isolated from the surface of PIPAAm hydrogel retains the natural ECM protein components, these ECM proteins have the role of adhesives, therefore, the cell structure can be obtained by the method of stacking and integrating multiple pieces of culture. multi-composite corneal stromal cell sheets. The transplantation method of multiple composite corneal stromal cell sheets is the same as that in Example 4.
实施例6多种细胞片纵向整合的多片复合角膜细胞片Example 6 Multiple Composite Keratocyte Sheets Vertically Integrated with Various Cell Sheets
将上述三种角膜细胞片(角膜上皮细胞片、角膜内皮细胞片和角膜基质细胞片)中的至少两种通过以下三种方法获得多种细胞片纵向整合的多片复合角膜细胞片:At least two of the above three corneal cell sheets (corneal epithelial cell sheet, corneal endothelial cell sheet, and corneal stromal cell sheet) are obtained by the following three methods to obtain multiple composite keratocyte sheets that are vertically integrated with various cell sheets:
方法一是单片重叠放置整合多片培养法:采用实施例5的多片复合角膜基质细胞片的制备的单片重叠放置整合多片培养方法,利用细胞片之间天然的ECM蛋白黏合作用获得多种细胞片纵向整合的多片复合角膜细胞片。The first method is single-sheet overlapping and integrated multi-sheet culture method: the single-sheet overlapping and integrated multi-sheet culture method prepared by the multi-sheet composite corneal stromal cell sheet in Example 5 is used, and the natural ECM protein adhesion between cell sheets is used to obtain Multiple composite keratocyte sheets vertically integrated with various cell sheets.
方法二是黏附蛋白液黏附法: 采用上述细胞片构建类似的方法构建三种角膜细胞片后,减少培养器皿的培养液至培养器皿的底部,采用上述黏附蛋白液,黏附蛋白液一种或者多种使用,将上述三种角膜细胞片单片逐片纵向黏附,防止细胞片卷曲和脱离,静置数分钟至数小时后,加入足够的培养液,常规培养数小时至数日。采用上述细胞片分离获取的方法获取一个多种细胞片纵向整合的多片复合角膜细胞片。The second method is the adhesive protein solution adhesion method: After constructing the three kinds of corneal cell sheets using the method similar to the above cell sheet construction, reduce the culture medium of the culture vessel to the bottom of the culture vessel, and use the above adhesive protein solution, one or more of the adhesive protein solutions For this kind of use, the above-mentioned three kinds of corneal cell sheets are adhered vertically one by one to prevent the cell sheets from curling and detachment. After standing for several minutes to several hours, enough culture medium is added, and the conventional culture is carried out for several hours to several days. A multi-piece composite keratocyte sheet in which various cell sheets are vertically integrated is obtained by adopting the method for separating and obtaining the above cell sheets.
方法三是上述两种方法混合应用:单片重叠放置整合多片培养法是依靠细胞片自身的粘附蛋白质黏合整合为多片复合角膜细胞片,但是,在某些情况下,这种重叠放置整合的多片复合细胞片可能黏合程度不够,易于松散,而混合应用黏附蛋白液可以弥补这种不足。The third method is the mixed application of the above two methods: the multi-sheet culture method relies on the adhesion protein of the cell sheet itself to adhere and integrate into multiple composite keratocyte sheets. However, in some cases, the overlapping placement The integrated multi-piece composite cell sheet may not be well bonded and easy to loosen, but the mixed application of adhesive protein solution can make up for this deficiency.
上述多种细胞片纵向整合的多片复合角膜细胞片包括:角膜上皮细胞片(单片)与角膜基质细胞片(多片)纵向整合后可以进行前板层角膜移植;角膜内皮细胞片(单片)与角膜基质细胞片(多片)纵向整合后可以进行后板层角膜移植;角膜上皮细胞片(单片)与角膜基质细胞片(多片)以及角膜内皮细胞片(单片)纵向整合可以进行全层角膜移植。上述角膜移植可以治疗角膜不同部位的相关病变。The multiple composite corneal cell sheets of the above-mentioned multiple cell sheets vertically integrated include: corneal epithelial cell sheet (single sheet) and corneal stromal cell sheet (multiple sheets) can be used for anterior lamellar keratoplasty after vertical integration; corneal endothelial cell sheet (single sheet) Posterior lamellar keratoplasty can be performed after longitudinal integration of corneal stromal cell sheets (multiple sheets) and corneal stromal cell sheets (multiple sheets); corneal epithelial cell sheets (single sheet) are vertically integrated with corneal stromal cell sheets (multiple sheets) Full-thickness corneal transplantation can be performed. The above-mentioned corneal transplantation can treat related lesions in different parts of the cornea.
实施例7视网膜色素上皮细胞片Example 7 retinal pigment epithelial cell sheet
酶消化或组织块贴壁法进行视网膜色素上皮细胞的分离和原代培养,常规培养视网膜色素上皮细胞,按照上述角膜上皮细胞片构建类似的方法构建视网膜色素上皮细胞片,将视网膜色素上皮细胞片移植于视网膜下间隙,可以治疗因为视网膜色素上皮细胞代谢障碍导致的眼底疾病。视网膜色素上皮细胞片移植优于视网膜色素上皮细胞悬液注射移植之处在于前者移植后可以保持视网膜色素上皮细胞生理状态下正常的极性,而正确的极性分布对维持视网膜色素上皮细胞的功能具有重要的意义。上述视网膜色素上皮细胞片的构建和移植的种子细胞除了应用视网膜色素上皮细胞、虹膜上皮细胞外,也可以应用其它的色素上皮细胞。Isolation and primary culture of retinal pigment epithelial cells by enzymatic digestion or tissue block attachment method, conventional culture of retinal pigment epithelial cells, construction of retinal pigment epithelial cell sheets according to the method similar to the above corneal epithelial cell sheet construction, the retinal pigment epithelial cell sheet Transplanted in the subretinal space, it can treat fundus diseases caused by metabolic disorders of retinal pigment epithelial cells. RPE cell sheet transplantation is superior to RPE cell suspension injection transplantation in that the former can maintain the normal polarity of RPE cells in physiological state after transplantation, and the correct polarity distribution is important for maintaining the function of RPE cells. is of great significance. In addition to retinal pigment epithelial cells and iris epithelial cells, other pigment epithelial cells can also be used as the seed cells for the above-mentioned construction of the retinal pigment epithelial cell sheet and transplantation.
实施例8视网膜神经感觉层细胞片Example 8 retinal neurosensory layer cell sheet
按视网膜神经感觉层细胞(光感受器细胞、中间神经元、神经节细胞)常规培养方法进行种子细胞培养,采用上述角膜上皮细胞片构建类似的方法构建视神经细胞片。视网膜神经感觉层细胞片移植可以治疗视网膜病变患者。上述视网膜神经感觉层细胞片的构建和移植的种子细胞除了应用视网膜前体细胞(retinal progenitor cells)外,也可以应用其它细胞。Seed cell culture was carried out according to the conventional culture method of retinal neurosensory layer cells (photoreceptor cells, interneurons, ganglion cells), and the optic nerve cell sheet was constructed by a method similar to the above-mentioned corneal epithelial cell sheet construction. Transplantation of neurosensory retinal cell sheets can treat patients with retinopathy. In addition to using retinal precursor cells (retinal progenitor cells), other cells can also be used for the construction of the retinal neurosensory layer cell sheet and the seed cells for transplantation.
实施例9视网膜细胞片Example 9 retinal cell sheet
将上述视网膜色素上皮细胞片和视网膜神经感觉层细胞片通过单细胞片重叠放置纵向整合或通过黏附蛋白液黏附纵向整合为复合视网膜细胞片,黏附蛋白液一种或者多种使用,视网膜细胞片移植可以治疗多种视网膜病变患者。The retinal pigment epithelial cell sheet and the retinal nerve sensory layer cell sheet are longitudinally integrated by overlapping single cell sheets or adhered to a composite retinal cell sheet by adhesive protein solution. One or more adhesive protein solutions are used for retinal cell sheet transplantation. It can treat patients with various retinal diseases.
实施例10皮肤细胞片Embodiment 10 skin cell sheet
与角膜细胞片的构建类似,既可以分别构建表皮上皮细胞片和真皮细胞片进行移植治疗,也可以将表皮上皮细胞片和真皮细胞片通过重叠整合或黏附纵向整合为多片复合皮肤细胞片,再进行移植,治疗皮肤病变。Similar to the construction of corneal cell sheets, epidermal epithelial cell sheets and dermal cell sheets can be constructed separately for transplantation treatment, and epidermal epithelial cell sheets and dermal cell sheets can be vertically integrated into multiple composite skin cell sheets through overlapping integration or adhesion. Transplantation is then performed to treat skin lesions.
实施例11牙周组织细胞片Example 11 Periodontal tissue cell sheet
通过酶消化组织块法分离牙周膜成纤维细胞并进行常规细胞培养,按上法构建牙周膜成纤维细胞片,移植于牙周,术后可以观察到牙龈的再生,再生牙龈与牙齿粘附紧密,可以治疗牙龈萎缩或其它牙龈病变。Isolate periodontal ligament fibroblasts by enzymatically digesting tissue blocks and carry out routine cell culture, construct periodontal ligament fibroblast sheets according to the above method, and transplant them in periodontium. Gingival regeneration can be observed after the operation, and the regenerated gingiva and tooth adhesion Adhering tightly, it can treat receding gums or other gum diseases.
实施例12心肌细胞片Embodiment 12 cardiomyocyte sheet
按上法构建心肌细胞片,多个心肌细胞片可以重叠放置纵向整合为多片复合心肌细胞片,也可以通过黏附纵向整合为多片复合细胞片。可以观察到多片复合细胞片的搏动及电生理活动,多片复合细胞片可以移植到心肌缺损部位。According to the method above to construct a cardiomyocyte sheet, multiple cardiomyocyte sheets can be stacked and vertically integrated into multiple composite cardiomyocyte sheets, or can be vertically integrated into multiple composite cell sheets through adhesion. The pulsation and electrophysiological activities of multiple composite cell sheets can be observed, and multiple composite cell sheets can be transplanted to myocardial defect sites.
按上述还可以构建肝组织、泌尿系统、呼吸系统等细胞片并进行移植治疗。According to the above, cell sheets such as liver tissue, urinary system, and respiratory system can also be constructed and transplanted.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100421476A CN101629162B (en) | 2009-08-26 | 2009-08-26 | Tissue engineering cell sheet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100421476A CN101629162B (en) | 2009-08-26 | 2009-08-26 | Tissue engineering cell sheet and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101629162A true CN101629162A (en) | 2010-01-20 |
| CN101629162B CN101629162B (en) | 2011-05-25 |
Family
ID=41574441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100421476A Expired - Fee Related CN101629162B (en) | 2009-08-26 | 2009-08-26 | Tissue engineering cell sheet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101629162B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102329727A (en) * | 2011-09-23 | 2012-01-25 | 重庆大学 | Preparing device of cell sheet for cold and hot regulation of temperature sensitive gel by utilizing semiconductor refrigerating sheets |
| CN103436444A (en) * | 2013-07-26 | 2013-12-11 | 上海瀚正生物技术服务有限公司 | Culture apparatus used for temperature sensitive cells, preparation method thereof and cell culturing method |
| CN104755611A (en) * | 2012-08-24 | 2015-07-01 | 独立行政法人理化学研究所 | Method for producing retinal pigment epithelial cell sheet |
| CN104861177A (en) * | 2015-04-27 | 2015-08-26 | 苏州大学 | Hydrogel material with thrombin-responsive thrombolysis capacity and preparation method thereof |
| CN110121552A (en) * | 2016-12-22 | 2019-08-13 | Dic株式会社 | Cell culture substrate |
| CN110229783A (en) * | 2019-05-22 | 2019-09-13 | 中国人民解放军总医院 | A method of stem cell diaphragm is prepared based on warm ware |
| CN110448731A (en) * | 2019-07-23 | 2019-11-15 | 中国人民解放军总医院 | Method for preparing human cardiomyocyte-derived stem cell membrane patch in temperature-sensitive culture dish |
| CN111936620A (en) * | 2019-02-28 | 2020-11-13 | 京东方科技集团股份有限公司 | Retinal pigment epithelial cell membrane and preparation method thereof |
| CN114466922A (en) * | 2019-10-01 | 2022-05-10 | 国立大学法人大阪大学 | Method for producing fibrin sheet |
| CN117398523A (en) * | 2023-06-29 | 2024-01-16 | 太原理工大学 | Preparation method of full-layer tissue engineering skin with epidermal ridges |
| CN119752775A (en) * | 2025-03-03 | 2025-04-04 | 上海尚瑞生物医药科技有限公司 | A method for non-destructively peeling a cell sheet in culture from a cell culture surface of a culture container |
-
2009
- 2009-08-26 CN CN2009100421476A patent/CN101629162B/en not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102329727A (en) * | 2011-09-23 | 2012-01-25 | 重庆大学 | Preparing device of cell sheet for cold and hot regulation of temperature sensitive gel by utilizing semiconductor refrigerating sheets |
| CN102329727B (en) * | 2011-09-23 | 2013-04-17 | 重庆大学 | Preparing device of cell sheet for cold and hot regulation of temperature sensitive gel by utilizing semiconductor refrigerating sheets |
| CN104755611A (en) * | 2012-08-24 | 2015-07-01 | 独立行政法人理化学研究所 | Method for producing retinal pigment epithelial cell sheet |
| CN103436444A (en) * | 2013-07-26 | 2013-12-11 | 上海瀚正生物技术服务有限公司 | Culture apparatus used for temperature sensitive cells, preparation method thereof and cell culturing method |
| CN104861177A (en) * | 2015-04-27 | 2015-08-26 | 苏州大学 | Hydrogel material with thrombin-responsive thrombolysis capacity and preparation method thereof |
| CN104861177B (en) * | 2015-04-27 | 2017-10-10 | 苏州大学 | Hydrogel material with thrombin-responsive thrombolysis capacity and preparation method thereof |
| CN110121552A (en) * | 2016-12-22 | 2019-08-13 | Dic株式会社 | Cell culture substrate |
| CN111936620A (en) * | 2019-02-28 | 2020-11-13 | 京东方科技集团股份有限公司 | Retinal pigment epithelial cell membrane and preparation method thereof |
| CN110229783A (en) * | 2019-05-22 | 2019-09-13 | 中国人民解放军总医院 | A method of stem cell diaphragm is prepared based on warm ware |
| CN110448731A (en) * | 2019-07-23 | 2019-11-15 | 中国人民解放军总医院 | Method for preparing human cardiomyocyte-derived stem cell membrane patch in temperature-sensitive culture dish |
| CN114466922A (en) * | 2019-10-01 | 2022-05-10 | 国立大学法人大阪大学 | Method for producing fibrin sheet |
| CN117398523A (en) * | 2023-06-29 | 2024-01-16 | 太原理工大学 | Preparation method of full-layer tissue engineering skin with epidermal ridges |
| CN117398523B (en) * | 2023-06-29 | 2024-07-09 | 太原理工大学 | Preparation method of full-layer tissue engineering skin with epidermal ridges |
| CN119752775A (en) * | 2025-03-03 | 2025-04-04 | 上海尚瑞生物医药科技有限公司 | A method for non-destructively peeling a cell sheet in culture from a cell culture surface of a culture container |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101629162B (en) | 2011-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101629162A (en) | Cell sheet engineering and preparation method thereof | |
| US9889228B2 (en) | Cultured cell sheet, production method, and tissue repair method using thereof | |
| JP4335873B2 (en) | Regenerated corneal endothelial cell sheet, production method and use thereof | |
| JP4921353B2 (en) | Cultured cell sheet, production method and use thereof | |
| JP6016751B2 (en) | Cultured periodontal ligament cell sheet, production method and use thereof | |
| KR101203434B1 (en) | Anterior ocular -associated cell sheet, three-dimensional construct and process for producing the same | |
| KR101141985B1 (en) | Cell sheets for ectocornea formation, method of producing the same and method of using the same | |
| JPWO2005087286A1 (en) | Biological tissue sheet, method for producing the same, and transplantation method using the same | |
| JP2006320304A (en) | Sealed cell culture vessel and cell culture method using the same | |
| JP4874514B2 (en) | Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof | |
| JP3935096B2 (en) | Highly engraftable corneal epithelial substitute cell sheet, production method and use thereof | |
| JP5227223B2 (en) | Cell culture support | |
| KR20070008590A (en) | Corneal epithelial sheet, preparation method thereof, and transplantation method using the same | |
| JP2004261532A (en) | Regenerated ectocornea cell sheet having high engraftment properties, its manufacturing method and utilizing method thereof | |
| JP5837530B2 (en) | Sealed cell culture vessel and cell culture method using the same | |
| Boschi et al. | Cutaneous tissue engineering and lower extremity wounds (part 1) | |
| WO2007029676A1 (en) | Biological tissue sheet and method for preparation thereof | |
| JP2011250804A (en) | Method for culturing multilayered epithelial cell, multilayered epithelial cell sheet obtained by the same and use of the sheet | |
| JP5264799B2 (en) | Anterior segment-related cell sheet, three-dimensional structure, and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110525 Termination date: 20130826 |